<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28230072</article-id>
<article-id pub-id-type="pmc">5436124</article-id>
<article-id pub-id-type="pii">npp201740</article-id>
<article-id pub-id-type="doi">10.1038/npp.2017.40</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model</article-title>
<alt-title alt-title-type="running">Cannabidiol improves poly I:C-induced behavioral deficits</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Osborne</surname>
<given-names>Ashleigh L</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Solowij</surname>
<given-names>Nadia</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5222-5637</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Babic</surname>
<given-names>Ilijana</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Xu-Feng</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5895-2253</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weston-Green</surname>
<given-names>Katrina</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Centre for Translational Neuroscience, School of Medicine, Faculty of Science, Medicine and Health, and Illawarra Health and Medical Research Institute, University of Wollongong</institution>, Wollongong, NSW, <country>Australia</country></aff>
<aff id="aff2"><label>2</label><institution>Centre for Medical and Molecular Biosciences, Faculty of Science, Medicine and Health, University of Wollongong</institution>, Wollongong, NSW, <country>Australia</country></aff>
<aff id="aff3"><label>3</label><institution>School of Psychology, Faculty of Social Sciences and Illawarra Health and Medical Research Institute, University of Wollongong</institution>, Wollongong, NSW, <country>Australia</country></aff>
<aff id="aff4"><label>4</label><institution>Illawarra Shoalhaven Local Health District</institution>, Wollongong, NSW, <country>Australia</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Centre for Translational Neuroscience, School of Medicine, Faculty of Science, Medicine and Health, and Illawarra Health and Medical Research Institute, University of Wollongong</institution>, Northfields Avenue, Wollongong, NSW 2522, <country>Australia</country>, Tel: +61 2 4252 8506, Fax: +61 2 4221 3151, E-mail: <email>katrina_green@uow.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>23</day>
<month>02</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>03</month>
<year>2017</year>
</pub-date>
<volume>42</volume>
<issue>7</issue>
<fpage>1447</fpage>
<lpage>1457</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>02</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>02</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 American College of Neuropsychopharmacology</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American College of Neuropsychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Neuropsychiatric disorders such as schizophrenia are associated with cognitive impairment, including learning, memory and attention deficits. Antipsychotic drugs are limited in their efficacy to improve cognition; therefore, new therapeutic agents are required. Cannabidiol (CBD), the non-intoxicating component of cannabis, has anti-inflammatory, neuroprotective and antipsychotic-like properties; however, its ability to improve the cognitive deficits of schizophrenia remains unclear. Using a prenatal infection model, we examined the effect of chronic CBD treatment on cognition and social interaction. Time-mated pregnant Sprague-Dawley rats (<italic>n</italic>=16) were administered polyinosinic-polycytidilic acid (poly I:C) (POLY; 4 mg/kg) or saline (CONT) at gestation day 15. Male offspring (PN56) were injected twice daily with 10 mg/kg CBD (CONT+CBD, POLY+CBD; <italic>n</italic>=12 per group) or vehicle (VEH; CONT+VEH, POLY+VEH; <italic>n</italic>=12 per group) for 3 weeks. Body weight, food and water intake was measured weekly. The Novel Object Recognition and rewarded T-maze alternation tests assessed recognition and working memory, respectively, and the social interaction test assessed sociability. POLY+VEH offspring exhibited impaired recognition and working memory, and reduced social interaction compared to CONT+VEH offspring (<italic>p&lt;</italic>0.01). CBD treatment significantly improved recognition, working memory and social interaction deficits in the poly I:C model (<italic>p&lt;</italic>0.01 <italic>vs</italic> POLY+VEH), did not affect total body weight gain, food or water intake, and had no effect in control animals (all <italic>p&gt;</italic>0.05). In conclusion, chronic CBD administration can attenuate the social interaction and cognitive deficits induced by prenatal poly I:C infection. These novel findings present interesting implications for potential use of CBD in treating the cognitive deficits and social withdrawal of schizophrenia.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>